Apps On Prescription and Big Pharma: A Beneficial Combination?
In this article, Torsten Christann addresses the question whether pharma corporations should add DiGA to their portfolio or no.
Enduring DiGA Success: Reaching Patients After Market Access
At WIG2 Digital Health Conference, Healthcare Expert Alexander Voigt talked about what matters after the regulatory market access: Reaching patients.